<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Yechezkel M</submitter><funding>European Research Council</funding><funding>Koret Foundation</funding><funding>Israel Science Foundation (ISF)</funding><pagination>169</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11344792</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>4(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Public reluctance to receive COVID-19 vaccination is associated with safety concerns. By contrast, the seasonal influenza vaccine has been administered for decades with a solid safety record and a high level of public acceptance. We compare the safety profile of the BNT162b2 COVID-19 booster vaccine to that of the seasonal influenza vaccine.&lt;h4>Methods&lt;/h4>We study a prospective cohort of 5079 participants in Israel and a retrospective cohort of 250,000 members of MHS selected randomly. We examine reactions to BNT162b2 mRNA COVID-19 booster and to influenza vaccinations. All prospective cohort participants wore a smartwatch and completed a daily digital questionnaire. We compare pre-vaccination and post-vaccination smartwatch heart-rate data, and a stress measure based o</pubmed_abstract><journal>Communications medicine</journal><pubmed_title>Comparison of physiological and clinical reactions to COVID-19 and influenza vaccination.</pubmed_title><pmcid>PMC11344792</pmcid><funding_grant_id>gift for Smart Cities and Digital Living</funding_grant_id><funding_grant_id>3409/19</funding_grant_id><funding_grant_id>#949850</funding_grant_id><pubmed_authors>Shmueli E</pubmed_authors><pubmed_authors>Qian G</pubmed_authors><pubmed_authors>Brandeau ML</pubmed_authors><pubmed_authors>Levi Y</pubmed_authors><pubmed_authors>Davidovitch N</pubmed_authors><pubmed_authors>Yamin D</pubmed_authors><pubmed_authors>Yechezkel M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Comparison of physiological and clinical reactions to COVID-19 and influenza vaccination.</name><description>&lt;h4>Background&lt;/h4>Public reluctance to receive COVID-19 vaccination is associated with safety concerns. By contrast, the seasonal influenza vaccine has been administered for decades with a solid safety record and a high level of public acceptance. We compare the safety profile of the BNT162b2 COVID-19 booster vaccine to that of the seasonal influenza vaccine.&lt;h4>Methods&lt;/h4>We study a prospective cohort of 5079 participants in Israel and a retrospective cohort of 250,000 members of MHS selected randomly. We examine reactions to BNT162b2 mRNA COVID-19 booster and to influenza vaccinations. All prospective cohort participants wore a smartwatch and completed a daily digital questionnaire. We compare pre-vaccination and post-vaccination smartwatch heart-rate data, and a stress measure based o</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Aug</publication><modification>2025-04-18T16:55:09.757Z</modification><creation>2025-04-07T04:24:43.776Z</creation></dates><accession>S-EPMC11344792</accession><cross_references><pubmed>39181950</pubmed><doi>10.1038/s43856-024-00588-7</doi></cross_references></HashMap>